City of Shreveport v. Purdue Pharma L P et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
| Ohio Northern District Court | |
| Judge: | Dan Aaron Polster |
| Case #: | 1:18-op-46064 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1332 Diversity-Product Liability |
| Case Filed: | Sep 17, 2018 |
| Case in other court: | Louisiana Western, 5:18-cv-01021 |
| Last checked: Friday Nov 08, 2019 6:36 PM EST |
|
Defendant
Janssen Pharmaceutica Inc.
|
Represented By
|
|
Defendant
Lynn Webster
|
Represented By
|
|
Defendant
Watson Laboratories Inc.
|
Represented By
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
Represented By
|
|
Defendant
Purdue Pharma L.P.
|
Represented By
|
|
Defendant
Purdue Pharma Inc.
|
Represented By
|
|
Defendant
Purdue Frederick Co Inc
|
Represented By
|
|
Defendant
Russell Portenoy
|
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
McKesson Corp.
|
Represented By
|
|
Defendant
Louisiana Wholesale Drug Company, Inc.
|
Represented By
|
|
Defendant
Johnson & Johnson
|
Represented By
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Insys Therapeutics Inc.
|
Represented By
|
|
Defendant
Scott Fishman
|
Represented By
|
|
Defendant
Perry Fine
|
Represented By
|
|
Defendant
Endo Pharmaceuticals Inc.
|
Represented By
|
|
Defendant
Endo Health Solutions Inc.
|
Represented By
|
|
Defendant
Cephalon Inc.
|
Represented By
|
|
Defendant
Cardinal Health Inc.
|
Represented By
|
|
Defendant
Amerisourcebergen Corp.
|
Represented By
|
|
Defendant
Allergan PLC
|
Represented By
|
|
Defendant
Actavis Pharma, Inc.
|
Represented By
|
|
Defendant
Actavis LLC
|
Represented By
|
|
Defendant
Actavis Inc
874 Walker Road, Suite C
Dover, DE 19904 |
Represented By
|
|
Plaintiff
City of Shreveport
505 Travis St
Shreveport, LA 71101 |
Represented By
|
| Docket last updated: 04/08/2019 6:19 PM EDT |
| Wednesday, August 08, 2018 | ||
| STATE COURT Service Returned Executed in the 1st JDC by Louisiana Long-arm service on Endo Health Solutions Inc with answer due 8/15/2018. ADMINISTRATIVE ENTRY: There is no PDF image with this entry. The PDF image can be found in Attachment #2 to Document #1 , Notice of Removal. (crt,Mitchell, Pam) [Transferred from lawd on 9/17/2018.] | ||
| SUMMONS ISSUED in the 1st JDC, Parish of Caddo, as to Actavis Inc, Actavis L L C, Actavis Pharma Inc, Allergan P L C, AmerisourceBergen Corp, Cardinal Health Inc, Cephalon Inc, Endo Health Solutions Inc, Endo Pharmaceuticals Inc, Perry Fine, Scott Fishman, Insys Therapeutics Inc, Janssen Pharmaceutica Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Louisiana Wholesale Drug Co Inc, McKesson Corp, Ortho-McNeil-Janssen Pharmaceuticals Inc, Russell Portenoy, Purdue Frederick Co Inc, Purdue Pharma Inc, Purdue Pharma L P, Teva Pharmaceuticals U S A Inc, Watson Laboratories Inc, and Lynn Webster. ADMINISTRATIVE ENTRY: There is no PDF image with this entry. The PDF image can be found in Attachment #3 to Document #1 , Notice of Removal. (crt,Mitchell, Pam) [Transferred from lawd on 9/17/2018.] | ||
| CASE Assigned to Chief Judge S Maurice Hicks, Jr and Magistrate Judge Mark L Hornsby. (crt,Mitchell, Pam) [Transferred from lawd on 9/17/2018.] | ||
| 1 | 1
NOTICE of Removal from 1st JDC Caddo Parish, Case Number 609579-C (Filing fee $400, receipt number 0536-3722767) filed by Endo Health Solutions Inc, Endo Pharmaceuticals Inc.(Attorney Kerry J Miller added to party Endo Health Solutions Inc(pty:dft), Attorney Kerry J Miller added to party Endo Pharmaceuticals Inc(pty:dft))(aty,Miller, Kerry) [Transferred from lawd on 9/17/2018.]
|
|
|
Att: 1
Exhibit 1 - MDL 2804 Order,
|
||
|
Att: 2
Exhibit 2 - Service and Citation,
|
||
|
Att: 3
Exhibit 3 - State Court Record,
|
||
|
Att: 4
Civil cover sheet
|
||
| 2 | 2
CORPORATE DISCLOSURE STATEMENT by Endo Health Solutions Inc, Endo Pharmaceuticals Inc identifying Corporate Parent Endo International plc for Endo Health Solutions Inc, Endo Pharmaceuticals Inc. (aty,Miller, Kerry) [Transferred from lawd on 9/17/2018.]
|
|
| Thursday, August 09, 2018 | ||
| 3 | 3
PROPOSED REMOVAL ORDER referred to Magistrate Judge Mark L Hornsby. (Public entry, but no electronic notice.) (crt,Mitchell, Pam) [Transferred from lawd on 9/17/2018.]
|
|
| Friday, August 10, 2018 | ||
| 4 | 4
REMOVAL ORDER regarding state court documents, pending motions, registry funds, and admission status of counsel. Signed by Magistrate Judge Mark L Hornsby on 8/10/2018. (crt,Putch, A) [Transferred from lawd on 9/17/2018.]
|
|
| Monday, August 13, 2018 | ||
| State Court ORDER signed on 7/18/2018 granting Motion for Extension of Time to File Responsive Pleadings re1 Petition for Damages filed in Case # 609,579-C, 1st Judicial District Court, Caddo Parish, Louisiana. ADMINISTRATIVE ENTRY as pleading filed within pdf of attachment to5 Supplemental Notice of Removal. AmerisourceBergen Corp answer due 9/14/2018; Cardinal Health Inc answer due 9/14/2018; McKesson Corp answer due 9/14/2018. (crt,Crick, S) [Transferred from lawd on 9/17/2018.] | ||
| State Court ORDER signed on 7/24/2018 granting Motion for Extension of Time to File Responsive Pleadings by Louisiana Wholesale Drug Co Inc re1 Petition for Damages filed in Case #609,579-C, 1st Judicial District Court, Caddo Parish, Louisiana. ADMINISTRATIVE ENTRY as pleading filed within pdf of attachment to5 Supplemental Notice of Removal. (crt,Crick, S) Modified on 8/14/2018 to modify docket text. (Crick, S). [Transferred from lawd on 9/17/2018.] | ||
| 5 | 5
Supplemental1 Notice of Removal by McKesson Corp.(aty,Adams, W) Modified on 8/14/2018 to modify docket text. (Crick, S). [Transferred from lawd on 9/17/2018.]
|
|
|
Att: 1
Exhibit A - state court record
|
||
| 6 | 6
CORPORATE DISCLOSURE STATEMENT by McKesson Corp. (aty,Adams, W) [Transferred from lawd on 9/17/2018.]
|
|
| Wednesday, August 15, 2018 | ||
| 7 | 7
Consent MOTION for Extension of Time to File Responsive Pleadings by Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals Inc, Endo Health Solutions Inc, Endo Pharmaceuticals Inc, Purdue Pharma L P, Purdue Pharma Inc, Purdue Frederick Co Inc, Teva Pharmaceuticals U S A Inc, Cephalon Inc, Watson Laboratories Inc, Actavis L L C, Actavis Pharma Inc, Insys Therapeutics Inc. Motions referred to Magistrate Judge Mark L Hornsby.(aty,Rookard, Kelly) Modified on 8/16/2018 to modify docket text and add filers. (Crick, S). [Transferred from lawd on 9/17/2018.]
|
|
|
Att: 1
Proposed order
|
||
| Thursday, August 16, 2018 | ||
| 8 | 8
NOTICE of Corporate Disclosure Statement Requirement re:7 Motion for Extension of Time to File Answer sent to Kelly Juneau Rookard on behalf of Actavis L L C, Actavis Pharma Inc, Cephalon Inc, Insys Therapeutics Inc, Janssen Pharmaceuticals Inc, Johnson & Johnson, Ortho-McNeil-Janssen Pharmaceuticals Inc, Purdue Frederick Co Inc, Purdue Pharma Inc, Purdue Pharma L P, Teva Pharmaceuticals U S A Inc, Watson Laboratories Inc. Corporate Disclosure Statement due by 8/30/2018. (crt,Crick, S) [Transferred from lawd on 9/17/2018.]
|
|
| Friday, August 17, 2018 | ||
| 9 | 9
ORDER granting7 Consent Motion for Extension of Time to File Responsive Pleadings. The Manufacturing Defendants are extended an extension of time to file responsive pleadings in the captioned matter, up to and until sixty (60) days following the J P M L's decision on transfer, or if transfer is denied, a ruling of this Court regarding remand, should Plaintiff move to remand. Signed by Magistrate Judge Mark L Hornsby on 8/17/2018. (crt,Crick, S) [Transferred from lawd on 9/17/2018.]
|
|
| Wednesday, August 22, 2018 | ||
| 10 | 10
MOTION for Extension of Time to File Answer with consent sought but not yet obtained by AmerisourceBergen Corp, Cardinal Health Inc, Louisiana Wholesale Drug Co Inc, McKesson Corp. Motions referred to Magistrate Judge Mark L Hornsby.(aty,Adams, W) [Transferred from lawd on 9/17/2018.]
|
|
|
Att: 1
Proposed order
|
||
| Thursday, August 23, 2018 | ||
| 11 | 11
ORDER granting10 Motion for Extension of Time to Answer re1 Petition for Damages. All defendants in this action, without waiver of any defenses, shall have up to, through and including 60 days after the later of (1) this Court's ruling on any motion to remand, should any party file one, or (2) the Judicial Panel on Multidistrict Litigation's final decision regarding whether to transfer this case to the MDL, to move, answer or otherwise respond to the Complaint. Signed by Magistrate Judge Mark L Hornsby on 8/23/2018. (crt,Crick, S) [Transferred from lawd on 9/17/2018.]
|
|
| Wednesday, August 29, 2018 | ||
| 12 | 12
CORPORATE DISCLOSURE STATEMENT by Janssen Pharmaceuticals Inc, Johnson & Johnson identifying Corporate Parent Johnson & Johnson, Other Affiliate Janssen Pharmaceutica Inc, Other Affiliate Ortho-McNeil-Janssen Pharmaceuticals Inc for Janssen Pharmaceuticals Inc. (aty,Rookard, Kelly) [Transferred from lawd on 9/17/2018.]
|
|
| Wednesday, September 05, 2018 | ||
| 13 | 13
SECOND NOTICE of Corporate Disclosure Statement Requirement, re:8 Notice of Corporate Disclosure Statement Requirement, sent to Kelly Juneau Rookard on behalf of Actavis L L C, Actavis Pharma Inc, Cephalon Inc, Insys Therapeutics Inc, Ortho-McNeil-Janssen Pharmaceuticals Inc, Purdue Frederick Co Inc, Purdue Pharma Inc, Purdue Pharma L P, Teva Pharmaceuticals U S A Inc, Watson Laboratories Inc. Show Cause Response due by 9/19/2018. (crt,Mitchell, Pam) [Transferred from lawd on 9/17/2018.]
|
|
| 14 | 14
CORPORATE DISCLOSURE STATEMENT by Actavis L L C, Actavis Pharma Inc, Cephalon Inc, Teva Pharmaceuticals U S A Inc, Watson Laboratories Inc identifying Corporate Parent Teva Pharmaceutical Industries Ltd for Actavis L L C, Actavis Pharma Inc, Watson Laboratories Inc; Corporate Parent Teva Phamaceuticals Industries Ltd, Corporate Parent Cupric Holding Co Inc for Cephalon Inc; Corporate Parent Orvet U K Unlimited, Corporate Parent Teva Pharmaceutical Holdings Cooperatieve U A, Corporate Parent Teva Pharmaceuticals Europe B V, Corporate Parent I V A X L L C for Teva Pharmaceuticals U S A Inc. (aty,Crisler, Richard) Modified on 9/5/2018 to add filer and modify docket text. (Crick, S). [Transferred from lawd on 9/17/2018.]
|
|
| Friday, September 14, 2018 | ||
| 15 | 15
NOTICE received via email from Clerk of Judicial Panel on Multidistrict Litigation transmitting Order Lifting Stay of Conditional Transfer Order (CTO-51) in MDL No.2804, IN RE: National Prescription Opiate Litigation advising case shall be transferred to the Northern District of Ohio upon request of the record.(crt,Whidden, C) [Transferred from lawd on 9/17/2018.]
|
|
|
Att: 1
CTO-51
|
||
| Monday, September 17, 2018 | ||
| 16 | 16
ORDER LIFTING STAY OF CONDITIONAL TRANSFER ORDER CTO # 51, directing transfer to Northern District of Ohio, In Re: National Prescription Opiate Litigation, MDL # 2804. Record electronically transmitted to receiving court. Case Terminated. All future pleadings should be filed with the newly assigned court. (crt,Whidden, C) [Transferred from lawd on 9/17/2018.]
|
|
| 17 | 17
CASE TRANSFERRED IN from District of Louisiana Western. Case number 5:18-cv-01021. Original file, certified copy of transfer order and docket sheet received.
|
|